Minimal Residual Disease Testing Global Market Report 2022: Sector to Reach $2.3 Billion by 2027 at a 14% CAGR

DUBLIN, May 18, 2023 /PRNewswire/ — The “Minimal Residual Disease Testing Market by Technology (PCR, Flow Cytometry, NGS), Application (Leukemia, Lymphoma, Solid Tumors), End User(Hospitals, Specialty Clinics, Diagnostic Labs, Research and Academic Institutes) & Region – Global Forecast…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.